Similar articles for PMID: 31192068

Year	Number of Results
1998	1
2000	1
2005	2
2006	4
2007	1
2008	2
2009	6
2010	5
2011	5
2012	6
2013	8
2014	6
2015	8
2016	7
2017	13
2018	16
2019	10
2020	6
2021	5
2022	7
2023	4
2024	0

1

Precipitating Factors and Treatment Outcomes of Hepatic Encephalopathy in Liver Cirrhosis.

Poudyal NS, Chaudhary S, Kc S, Paudel BN, Basnet BK, Mandal A, Kafle P, Chaulagai B, Mojahedi A, Paudel MS, Shrestha B, Gayam V. Poudyal NS, et al. Cureus. 2019 Apr 2;11(4):e4363. doi: 10.7759/cureus.4363. Cureus. 2019. PMID: 31192068 Free PMC article.

2

A randomized, double-blind, controlled trial comparing rifaximin plus lactulose with lactulose alone in treatment of overt hepatic encephalopathy.

Sharma BC, Sharma P, Lunia MK, Srivastava S, Goyal R, Sarin SK. Sharma BC, et al. Am J Gastroenterol. 2013 Sep;108(9):1458-63. doi: 10.1038/ajg.2013.219. Epub 2013 Jul 23. Am J Gastroenterol. 2013. PMID: 23877348 Clinical Trial.

3

[Reduction of hospital stay with the use of L-ornithine L-aspartate (LOLA) in patients with hepatic encephalopathy].

Abdo-Francis JM, Pérez-Hernández JL, Hinojosa-Ruiz A, Hernández-Vásquez JR. Abdo-Francis JM, et al. Rev Gastroenterol Mex. 2010;75(2):135-41. Rev Gastroenterol Mex. 2010. PMID: 20615780 Spanish.

4

L-ornithine L-aspartate in acute treatment of severe hepatic encephalopathy: A double-blind randomized controlled trial.

Jain A, Sharma BC, Mahajan B, Srivastava S, Kumar A, Sachdeva S, Sonika U, Dalal A. Jain A, et al. Hepatology. 2022 May;75(5):1194-1203. doi: 10.1002/hep.32255. Epub 2021 Dec 21. Hepatology. 2022. PMID: 34822189 Clinical Trial.

5

Precipitating factors and the outcome of hepatic encephalopathy in liver cirrhosis.

Mumtaz K, Ahmed US, Abid S, Baig N, Hamid S, Jafri W. Mumtaz K, et al. J Coll Physicians Surg Pak. 2010 Aug;20(8):514-8. J Coll Physicians Surg Pak. 2010. PMID: 20688015

6

Comparison of Rifaximin Plus Lactulose with the Lactulose Alone for the Treatment of Hepatic Encephalopathy.

Ahire K, Sonawale A. Ahire K, et al. J Assoc Physicians India. 2017 Aug;65(8):42-46. J Assoc Physicians India. 2017. PMID: 28799305

7

Primary Prophylaxis to Prevent the Development of Hepatic Encephalopathy in Cirrhotic Patients with Acute Variceal Bleeding.

Higuera-de-la-Tijera F, Servín-Caamaño AI, Salas-Gordillo F, Pérez-Hernández JL, Abdo-Francis JM, Camacho-Aguilera J, Alla SN, Jiménez-Ponce F. Higuera-de-la-Tijera F, et al. Can J Gastroenterol Hepatol. 2018 Jul 10;2018:3015891. doi: 10.1155/2018/3015891. eCollection 2018. Can J Gastroenterol Hepatol. 2018. PMID: 30079329 Free PMC article. Clinical Trial.

8

Complications of Cirrhosis in Primary Care: Recognition and Management of Hepatic Encephalopathy.

Flamm SL. Flamm SL. Am J Med Sci. 2018 Sep;356(3):296-303. doi: 10.1016/j.amjms.2018.06.008. Epub 2018 Jun 19. Am J Med Sci. 2018. PMID: 30286824 Free article. Review.

9

Efficacy of L-ornithine-L-aspartate as an adjuvant therapy in cirrhotic patients with hepatic encephalopathy.

Abid S, Jafri W, Mumtaz K, Islam M, Abbas Z, Shah HA, Hamid S. Abid S, et al. J Coll Physicians Surg Pak. 2011 Nov;21(11):666-71. J Coll Physicians Surg Pak. 2011. PMID: 22078345 Clinical Trial.

10

Management of overt hepatic encephalopathy.

Sharma P, Sharma BC. Sharma P, et al. J Clin Exp Hepatol. 2015 Mar;5(Suppl 1):S82-7. doi: 10.1016/j.jceh.2014.04.004. Epub 2014 May 10. J Clin Exp Hepatol. 2015. PMID: 26041964 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

110 results

Results by year